BDFS Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.48M Sell
5,609
-7
-0.1% -$1.85K 0.73% 23
2026
Q2
$1.43M Buy
5,616
+6
+0.1% +$1.4K 0.62% 28
2026
Q1
$1.37M Sell
5,610
-39
-0.7% -$9.08K 0.66% 24
2025
Q4
$1.17M Hold
5,649
– – 0.59% 27

Other funds holding JNJ

BDFS Capital's JNJ Position: Q3 2026 in Review

BDFS Capital reduced its Johnson & Johnson (JNJ) stake by 0.12% in Q3 2026, selling an estimated $1.85K and leaving 5,609 shares worth $1.48M. The position accounts for 0.73% of the portfolio, ranked #23.

BDFS Capital first reported a position in JNJ in Q4 2025 and has held it in 4 quarters since. 4,737 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • BDFS Capital held 5,609 shares of Johnson & Johnson worth $1.48M as of Q3 2026.
  • BDFS Capital sold 7 Johnson & Johnson shares in Q3 2026, an estimated $1.85K.
  • Johnson & Johnson made up 0.73% of BDFS Capital's portfolio in Q3 2026, its #23 holding.
  • BDFS Capital first reported a position in Johnson & Johnson in Q4 2025 and has held it in 4 quarters since.
  • 4,737 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on BDFS Capital's 13F filing for Q3 2026, filed 14 Oct 2026.